NCT01204788 Prophylactic White Cell Transfusions Versus Therapeutic White Cell Transfusions in Patients With Leukemia Status TERMINATED Phase PHASE2
NCT01200485 Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2 Status COMPLETED Phase PHASE2
NCT01191749 Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL) Status TERMINATED Phase PHASE2
NCT01191541 Cytarabine (Ara-C) in Children With Acute Promyelocytic Leukemia (APL) Status COMPLETED Phase PHASE4
NCT01185886 Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia Status UNKNOWN Phase N/A
NCT01184274 A Phase I Study of SB939 in Pediatric Patients With Refractory Solid Tumours and Leukemia Status COMPLETED Phase PHASE1
NCT01174615 Collection of Blood and/or Bone Marrow for Investigation and Characterization of Normal and Abnormal Cell Growth Status WITHDRAWN Phase N/A
NCT01169363 Biomarkers in Bone Marrow and Blood Samples From Older Patients With Acute Myeloid Leukemia Treated With Cytarabine-Based Therapy Status COMPLETED Phase N/A
NCT01164709 Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer Status COMPLETED Phase PHASE1
NCT01164163 INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease Status COMPLETED Phase PHASE1
NCT01162551 Trial of Sirolimus and Methotrexate in Relapsed/Refractory Lymphoblastic Leukemia and Lymphoma Status COMPLETED Phase PHASE2
NCT01162031 Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia Status WITHDRAWN Phase PHASE2
NCT01156883 Combination Chemotherapy in Treating Young Adult Patients With Acute Lymphoblastic Leukemia Status COMPLETED Phase NA
NCT01154439 Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Status COMPLETED Phase PHASE1
NCT01150656 Obatoclax Mesylate in Samples From Young Patients With Acute Myeloid Leukemia Status COMPLETED Phase N/A
NCT01150058 Drug Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia Status COMPLETED Phase N/A
NCT01149668 A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer Status COMPLETED Phase PHASE1
NCT01145469 Biomarkers in DNA Samples From Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine-Based Therapy Status COMPLETED Phase N/A